REGEnLIFE


REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders.Our company supports a non-invasive medical approach based on physical sciences.Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs.Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process.Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia.

Industries

Health Care
Life Science
Medical Device
Neuroscience
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

REGEnLIFE

Montpellier, Occitanie, France


Products

RGn500

A photobiomodulation medical device used in preclinical and clinical studies for neurological disorders such as Alzheimer's and brain trauma.

REGEnBRAIN

A non-invasive medical device for the treatment of concussions utilizing photobiomodulation.

RGn530

An early medical technology for the treatment of Alzheimer’s disease based on magnetic and photonic emissions.

RGn550

A photobiomodulation device utilizing a helmet equipped with biophotonic modules designed to evaluate and treat acute concussion syndrome in athletes.

RGn535

A miniaturized PBM neurostimulation medical device for preclinical research in murine models, featuring dorsoventral modules.

Expertise Areas

  • Digital engagement
  • Web-based user support

Key Technologies

  • Social media widget iframe embedding
  • Web-based contact and FAQ pages

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.